With the recent developments in the atopic dermatitis (AD) market, the field is becoming more competitive as novel therapies are soon anticipated to enter the market. This evolution may benefit AD ...

The facility is set to produce DS for biopharmaceuticals, leveraging the company's protein engineering and antibody ...